During tumor progression, the cancer cells originating from ER− cells maintain ER− status, while those originating from ER+ cells can either maintain their ER+ and slow-proliferation status or lose their ER expression to become ER− and more aggressive breast cancer cells and gain fast-proliferation status [68]. This evidence concerns the gene ESR1 and neoplasm.